X0508 4 2023-05-25 0 0001016504 INTEGRATED BIOPHARMA INC INBP 0001064900 RIVA SHEPPARD C/O 225 LONG AVENUE HILLSIDE NJ 07205 1 1 1 0 Co-Chief Executive Officer 0 Common Stock 2023-05-25 2023-05-25 4 A 0 3410512 0.4 A 3426212 I As Co-Executor of the Estate of E Gerald Kay and as Trustee of the Emily Sheppard Trust Common Stock 2023-09-20 2023-09-20 4 A 0 50000 0.09 A 1273467 D Stock Option (right to buy) 0.23 2023-05-25 2023-05-25 4 A 0 150000 0 A 2019-05-24 2024-03-20 Common Stock 150000 150000 I As Co-Executor of the Estate of E Gerald Kay Stock Option (right to buy) 0.72 2023-05-25 2023-05-25 4 A 0 66667 0 A 2021-11-04 2024-03-20 Common Stock 66667 66667 I As Co-Executor of the Estate of E Gerald Kay Stock Option (right to buy) 1.045 2023-05-25 2023-05-25 4 A 0 21667 0 A 2022-11-03 2024-03-20 Common Stock 21667 21667 I As Co-Executor of the Estate of E Gerald Kay Stock Option (right to buy) 0.09 2023-09-20 2023-09-20 4 D 0 50000 0 D 2015-06-02 2025-06-02 Common Stock 50000 200000 D Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay. 3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust. 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015. 25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022. 33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date. /s/ Riva Sheppard 2023-09-21